Best Practice & Research Clinical Rheumatology
Volume 22, Issue 6 , Pages 1127-1139 , December 2008

Imaging of metabolic bone diseases

  • Glenn Haugeberg, MD, PhD (Professor)

      Affiliations

    • Corresponding Author InformationTel.: +47 38073142; Fax: +47 38073143.

References 

  1. Sambrook PN, Hughes DR, Nelson AE, et al. Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the Rheumatic Diseases. 2003;62:1215–1217
  2. Lane NE, Yao W, Balooch M, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. Journal of Bone and Mineral Research. 2006;21:466–476
  3. Jørgensen JT, Andersen PB, Rosholm A, Hannover Bjarnason N. Digital x-ray radiogrammetry: a new appendicular bone densitometric method with high precision. Clinical Physiology. 2000;20:330–335
  4. Blake GM, Fogelman I. Technical principles of dual energy x-ray absorptiometry. Seminars In Nuclear Medicine. 1997;27:210–228
  5. Njeh CF, Fuerst T, Diessel E, Genant HK. Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporosis International. 2001;12:1–15
  6. Cann CE. Quantitative CT for determination of bone mineral density: a review. Radiology. 1988;166:509–522
  7. Jesserer H, Zita G, Drexler H. Bone scintigraphy in osteodystrophia deformans (Paget's disease). Fortschritte der Medizin. 1977;95:2451–2458
  8. Fogelman I, Carr D, Boyle IT. The role of bone scanning in Paget's disease. Metabolic Bone Disease & Related Research. 1981;3:243–254
  9. Vellenga CJ, Bijvoet OL, Pauwels EK. Bone scintigraphy and radiology in Paget's disease of bone: a review. American Journal of Physiologic Imaging. 1988;3:154–168
  10. Alvarez L, Peris P, Guanabens N, et al. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment. Rheumatology (Oxford). 2004;43:869–874
  11. Fogelman I, Carr D. A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease. European Journal of Nuclear Medicine. 1980;5:417–421
  12. Pons F, Alvarez L, Peris P, et al. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity. Nuclear Medicine Communications. 1999;20:525–528
  13. Peris P, Alvarez L, Vidal S, et al. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy. Clinical and Experimental Rheumatology. 2007;25:206–210
  14. Ang G, Feiglin D, Moses AM. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels. Endocrine Practice. 2003;9:280–283
  15. Oesterreich FU, Heller M, Triebel HJ, Kruse HP. Morphology of Paget's osteodystrophia deformans in the computed tomogram. Rofo. 1988;149:603–608
  16. Trumble TE, Wu RK, Ruwe PA. Paget's disease in the hand: correlation of magnetic resonance imaging with histology. The Journal of Hand Surgery[Am]. 1990;15:504–507
  17. Vuillemin-Bodaghi V, Parlier-Cuau C, Cywiner-Golenzer C, et al. Multifocal osteogenic sarcoma in Paget's disease. Skeletal Radiology. 2000;29:349–353
  18. Seret P, Basle MF, Rebel A, et al. Sarcomatous degeneration in Paget's bone disease. Journal of Cancer Research and Clinical Oncology. 1987;113:392–399
  19. Fransen P, Mestdagh C, Dardenne G. Pagetic sarcoma of the calvarium: report of two cases. Acta Neurologica Belgica. 1998;98:352–355
  20. Fogelman I, McKillop JH, Bessent RG, et al. The role of bone scanning in osteomalacia. Journal of Nuclear Medicine. 1978;19:245–248
  21. Fogelman I, McKillop JH, Greig WR, Boyle IT. Pseudofracture of the ribs detected by bone scanning. Journal of Nuclear Medicine. 1977;18:1236–1237
  22. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. American Journal of Medicine. 1993;94:646–650
  23. Haugeberg G, Uhlig T, Falch JA, et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis & Rheumatism. 2000;43:522–530
  24. Gough AK, Lilley J, Eyre S, et al. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344:23–27
  25. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993;341:72–75
  26. Legrand E, Chappard D, Pascaretti C, et al. Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis. Journal of Bone and Mineral Research. 2000;15:13–19
  27. Crabtree NJ, Kroger H, Martin A, et al. Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporosis International. 2002;13:48–54
  28. Laan RF, van Riel PL, van de Putte LB. Bone mass in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 1992;51:826–832
  29. Rosholm A, Hyldstrup L, Baeksgaard L, et al. Estimation of bone mineral density by digital x-ray radiogrammetry: theoretical background and clinical testing. Osteoporosis International. 2001;12:961–969
  30. Johnell O, Onnby K, Redlund-Johnell I. Superior short-term in vivo precision with digital x-ray radiogrammetry compared to DXA. Journal of Bone and Mineral Research. 2000;15(Suppl. 1):SU280
  31. Sambrook P, Raj A, Hunter D, et al. Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. The Journal of Rheumatology. 2001;28:1063–1067
  32. Blanckaert F, Cortet B, Coquerelle P, et al. Contribution of calcaneal ultrasonic assessment to the evaluation of postmenopausal and glucocorticoid-induced osteoporosis. Revue du Rhumatisme (English ed.). 1997;64:305–313
  33. Bonnick SL, Johnston CC, Kleerekoper M, et al. Importance of precision in bone density measurements. Journal of Clinical Densitometry. 2001;4:105–110
  34. Kanis JA, Delmas P, Burckhardt P, et al. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporosis International. 1997;7:390–406
  35. Kanis JA, Melton LJ, Christiansen C, et al. The diagnosis of osteoporosis. [see comments] Journal of Bone and Mineral Research. 1994;9:1137–1141
  36. WHO Study Group . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: World Health Organization; 1994;
  37. Chen Z, Maricic M, Lund P, et al. How the new Hologic hip normal reference values affect the densitometric diagnosis of osteoporosis. Osteoporosis International. 1998;8:423–427
  38. Looker AC, Orwoll ES, Johnston CC, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. Journal of Bone and Mineral Research. 1997;12:1761–1768
  39. Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporosis International. 1998;8:468–489
  40. Kanis JA, McCloskey EV, Johansson H, et al. A reference standard for the description of osteoporosis. Bone 2008; 42: 467–475. Available from: <http://www.ncbi.nlm.nih.gov/pubmed/18180210?ordinalpos=16&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum>.
  41. Kanis JA, Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporosis International. 2000;11:192–202
  42. Binkley N, Bilezikian JP, Kendler DL, et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. Journal of Clinical Densitometry. 2006;9:4–14
  43. Binkley N, Krueger D. Osteoporosis in men. WMJ. 2002;101:28–32
  44. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–1259
  45. Haugeberg G, Green MJ, Conaghan PG, et al. Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2007;66:1513–1517
  46. Cullum ID, Ell PJ, Ryder JP. X-ray dual-photon absorptiometry: a new method for the measurement of bone density. British Journal of Radiology. 1989;62:587–592
  47. Johnson J, Dawson-Hughes B. Precision and stability of dual-energy X-ray absorptiometry measurements. Calcified Tissue International. 1991;49:174–178
  48. LeBlanc AD, Schneider VS, Engelbretson DA, Evans HJ. Precision of regional bone mineral measurements obtained from total-body scans. Journal of Nuclear Medicine. 1990;31:43–45
  49. Kelly TL, Slovik DM, Neer RM. Calibration and standardization of bone mineral densitometers. Journal of Bone and Mineral Research. 1989;4:663–669
  50. Laskey MA, Flaxman ME, Barber RW, et al. Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy X-ray absorptiometers. British Journal of Radiology. 1991;64:1023–1029
  51. Lewis MK, Blake GM, Fogelman I. Patient dose in dual x-ray absorptiometry. Osteoporosis International. 1994;4:11–15
  52. Laan RF, van Riel PL, van de Putte LB, et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Annals of Internal Medicine. 1993;119:963–968
  53. Lane NE, Sanchez S, Modin GW, et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. The Journal of Clinical Investigation. 1998;102:1627–1633
  54. Rehman Q, Lang T, Modin G, Lane NE. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy. Arthritis & Rheumatism. 2002;46:1292–1297
  55. Patel R, Blake GM, Fogelman I. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis. Calcified Tissue International. 2007;80:89–96
  56. Blake GM, Chinn DJ, Steel SA, et al. A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporosis International. 2005;16:2149–2156
  57. Patel R, Blake GM, Fogelman I. An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry. Osteoporosis International. 2004;15:497–504
  58. Barnett E, Nordin B. The radiological diagnosis of osteoporosis: a new approach. Clinical Radiology. 1960;11:166–174
  59. Hyldstrup L, Nielsen SP. Metacarpal index by digital X-ray radiogrammetry: normative reference values and comparison with dual X-ray absorptiometry. Journal of Clinical Densitometry. 2001;4:299–306
  60. Nielsen SP. The metacarpal index revisited: a brief overview. Journal of Clinical Densitometry. 2001;4:199–207
  61. Hyldstrup L, Jorgensen JT, Sorensen TK, Baeksgaard L. Response of cortical bone to antiresorptive treatment. Calcified Tissue International. 2001;68:135–139
  62. Boonen S, Nijs J, Borghs H, et al. Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital X-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study. Osteoporosis International. 2005;16:93–100
  63. Reed MR, Murray JR, Abdy SE, et al. The use of digital X-ray radiogrammetry and peripheral dual energy X-ray absorptiometry in patients attending fracture clinic after distal forearm fracture. Bone. 2004;34:716–719
  64. Bouxsein ML, Palermo L, Yeung C, Black DM. Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures. Osteoporosis International. 2002;13:358–365
  65. Bottcher J, Pfeil A, Mentzel H, et al. Peripheral bone status in rheumatoid arthritis evaluated by digital X-ray radiogrammetry and compared with multisite quantitative ultrasound. Calcified Tissue International. 2006;78:25–34
  66. Haugeberg G, Lodder MC, Lems WF, et al. Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50–70 year old female patients with rheumatoid arthritis: cross-sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Annals of the Rheumatic Diseases. 2004;63:1331–1334
  67. Barkmann R, Laugier P, Moser U, et al. A method for the estimation of femoral bone mineral density from variables of ultrasound transmission through the human femur. Bone. 2007;40:37–44
  68. Dencks S, Barkmann R, Padilla F, et al. Wavelet-based signal processing of in vitro ultrasonic measurements at the proximal femur. Ultrasound In Medicine and Biology. 2007;33:970–980
  69. Stewart A, Felsenberg D, Eastell R, et al. Relationship between risk factors and QUS in a European population: the OPUS study. Bone. 2006;39:609–615
  70. Gluer CC, Eastell R, Reid DM, et al. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. Journal of Bone and Mineral Research. 2004;19:782–793
  71. Gluer CC. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus Group. Journal of Bone and Mineral Research. 1997;12:1280–1288
  72. Huopio J, Kroger H, Honkanen R, et al. Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporosis International. 2004;15:190–195
  73. Hans D, Schott AM, Duboeuf F, et al. Does follow-up duration influence the ultrasound and DXA prediction of hip fracture? The EPIDOS prospective study. Bone. 2004;35:357–363
  74. Fujiwara S, Sone T, Yamazaki K, et al. Heel bone ultrasound predicts non-spine fracture in Japanese men and women. Osteoporosis International. 2005;16:2107–2112
  75. Bauer DC, Ewing SK, Cauley JA, et al. Quantitative ultrasound predicts hip and non-spine fracture in men: the MrOS study. Osteoporosis International. 2007;18:771–777
  76. Krieg MA, Cornuz J, Ruffieux C, et al. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or = 70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. Journal of Bone and Mineral Research. 2006;21:1457–1463
  77. Hans D, Srivastav SK, Singal C, et al. Does combining the results from multiple bone sites measured by a new quantitative ultrasound device improve discrimination of hip fracture?. Journal of Bone and Mineral Research. 1999;14:644–651
  78. Gluer CC, Wu CY, Genant HK. Broadband ultrasound attenuation signals depend on trabecular orientation: an in vitro study. Osteoporosis International. 1993;3:185–191
  79. Gluer CC, Wu CY, Jergas M, et al. Three quantitative ultrasound parameters reflect bone structure. Calcified Tissue International. 1994;55:46–52
  80. Daens S, Peretz A, de M V, Moris M, Bergmann P. Efficiency of quantitative ultrasound measurements as compared with dual-energy X-ray absorptiometry in the assessment of corticosteroid-induced bone impairment. Osteoporosis International. 1999;10:278–283
  81. Peel NF, Moore DJ, Barrington NA, et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Annals of the Rheumatic Diseases. 1995;54:801–806
  82. Luengo M, Picado C, Del Rio L, et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax. 1991;46:803–806
  83. Naganathan V, Jones G, Nash P, et al. Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Archives of Internal Medicine. 2000;160:2917–2922
  84. Selby PL, Halsey JP, Adams KR, et al. Corticosteroids do not alter the threshold for vertebral fracture. Journal of Bone and Mineral Research. 2000;15:952–956
  85. Cheng S, Fan B, Wang L, et al. Ultrasound and bone mineral density assessments of the calcaneus in people with various musculoskeletal conditions. Bone. 1998;23(Suppl.):S458
  86. Martin JC, Munro R, Campbell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. British Journal of Rheumatology. 1997;36:43–49
  87. Haugeberg G, Orstavik RE, Uhlig T, et al. Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population. Osteoporosis International. 2003;14:312–319
  88. Fogelman I, Carr D. A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clinical Radiology. 1980;31:321–326
  89. Spitz J, Lauer I, Tittel K, Wiegand H. Scintimetric evaluation of remodeling after bone fractures in man. Journal of Nuclear Medicine. 1993;34:1403–1409
  90. Laib A, Beuf O, Issever A, et al. Direct measures of trabecular bone architecture from MR images. Advances In Experimental Medicine and Biology. 2001;496:37–46
  91. Borah B, Gross GJ, Dufresne TE, et al. Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anatomical Record. 2001;265:101–110
  92. Ladinsky GA, Wehrli FW. Noninvasive assessment of bone microarchitecture by MRI. Current Osteoporosis Reports. 2006;4:140–147
  93. Carballido-Gamio J, Majumdar S. Clinical utility of microarchitecture measurements of trabecular bone. Current Osteoporosis Reports. 2006;4:64–70
  94. Lespessailles E, Chappard C, Bonnet N, Benhamou CL. Imaging techniques for evaluating bone microarchitecture. Joint Bone Spine. 2006;73:254–261
  95. Bauer JS, Link TM, Burghardt A, et al. Analysis of trabecular bone structure with multidetector spiral computed tomography in a simulated soft-tissue environment. Calcified Tissue International. 2007;80:366–373
  96. Krug R, Carballido-Gamio J, Burghardt AJ, et al. Wavelet-based characterization of vertebral trabecular bone structure from magnetic resonance images at 3 T compared with micro-computed tomographic measurements. Magnetic Resonance in Imaging. 2007;25:392–398
  97. Graeff C, Timm W, Nickelsen TN, et al. Monitoring teriparatide-associated changes in vertebral microstructure by high-resolution CT in vivo: results from the EUROFORS study. Journal of Bone and Mineral Research. 2007;22:1426–1433

PII: S1521-6942(08)00115-0

doi: 10.1016/j.berh.2008.09.016

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 6 , Pages 1127-1139 , December 2008

Article Tools